Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 27;27(2):100113.
doi: 10.1016/j.ccrj.2025.100113. eCollection 2025 Jun.

Respiratory syncytial virus infection in adult and paediatric patients admitted to intensive care in Australia: A nation-wide comparison with COVID-19

Affiliations

Respiratory syncytial virus infection in adult and paediatric patients admitted to intensive care in Australia: A nation-wide comparison with COVID-19

Yaodong Tang et al. Crit Care Resusc. .

Abstract

Objective: To assess the characteristics, treatments and outcomes of paediatric and adult intensive care unit (ICU) patients with respiratory syncytial virus (RSV) infection, and compare these with coronavirus disease (COVID-19) during the same period.

Design setting and participants: We conducted a multicenter, prospective, observational study using data from the short period incidence study of severe acute respiratory infection (SPRINT SARI) Australia, in 38 Australian ICUs from 1 June 2022 to 1 September 2024. Demographic, treatment, and outcome data were analysed for patients with confirmed RSV or COVID-19. The primary outcome was in-hospital mortality.

Results: Of 4693 patients were recorded in the SPRINT-SARI database, 2540 met inclusion criteria. RSV was more common in paediatric patients (410/620, 62%) than in adults (249/1920, 13%). Adult with RSV had more chronic pulmonary conditions than those with COVID-19. Paediatric patients with RSV had fewer comorbidities and less invasive mechanical ventilation (IMV) compared to those with COVID-19 (P < 0.05), but required longer duration of IMV once intubated. In-hospital mortality was similar for both adult RSV and COVID-19 (36/249, 14.5%) vs (260/1671, 15.6%), and paediatric RSV(3/410 [0.7%] vs 7/210 [3.3%] P = 0.07). Mortality in adults was associated with male sex, older age, comorbidities, and IMV. Mortality in children was associated with IMV only.

Conclusions: RSV infection can result in an attributable number of ICU admission in Australia, especially in specific populations including young children and older adults with respiratory comorbidities. Mortality in patients admitted to ICU is similar to COVID-19.

Keywords: COVID-19; ICU mortality; Respiratory syncytial virus (RSV); Severe acute respiratory infection (SARI) intensive care unit (ICU).

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Andrew Udy, Aidan Burrell reports financial support was provided by Australian Government Department of Health and Aged Care. Andrew Udy, Aidan Burrell reports a relationship with Australian Government Department of Health and Aged Care that includes: funding grants. Co-authors Andrew Udy, Edward Litton, Mark Plummer all serve on the editorial board of Critical Care and Resuscitation. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Time flow diagram of RSV and COVID admissions in adult and paediatric populations. RSV, respiratory syncytial virus; COVID, coronavirus disease.
Fig. 2
Fig. 2
Age distribution of COVID and RSV patients. COVID, coronavirus disease; RSV, respiratory syncytial virus.
Fig. 3
Fig. 3
Multivariable analysis of risk factors for in-hospital mortality in adult patients.
Fig. 4
Fig. 4
Multivariable analysis of risk factors for in-hospital mortality in paediatric patients.

References

    1. Coussement J., Zuber B., Garrigues E., Gros A., Vandueren C., Epaillard N., et al. Characteristics and outcomes of patients in the ICU with respiratory syncytial virus compared with those with influenza infection: a multicenter matched cohort study. Chest. 2022;161(6):1475–1484. - PubMed
    1. Heo M., Jeong J.H., Ju S., Lee S.J., Jeong Y.Y., Lee J.D., et al. Comparison of clinical features and outcomes between SARS-CoV-2 and non-SARS-CoV-2 respiratory viruses associated acute respiratory distress syndrome: retrospective analysis. J Clin Med. 2022;11(8) - PMC - PubMed
    1. Kaler J., Hussain A., Patel K., Hernandez T., Ray S. Respiratory syncytial virus: a comprehensive review of transmission, pathophysiology, and manifestation. Cureus. 2023;15(3) - PMC - PubMed
    1. Department of Health and Aged Care . 2024. National notifiable diseases surviellance system (NNDSS)https://www.health.gov.au/our-work/nndss=The20NNDSS20coordinates20nation... March 2024 [cited 2024 08/11/2024]; Available from: ; 2024.
    1. Self A., Van Buskirk J., Clark J., Cochrane J.E., Knibbs L., Cass-Verco J., et al. Respiratory syncytial virus disease morbidity in Australian infants aged 0 to 6 months: a systematic review with narrative synthesis. BMC Public Health. 2023;23(1):2560. - PMC - PubMed

LinkOut - more resources